Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The COVID-19 pandemic has already claimed considerable lives. There are major concerns in Africa due to existing high prevalence rates for both infectious and non-infectious diseases and limited resources in terms of personnel, beds and equipment. Alongside this, concerns that lockdown and other measures will have on prevention and management of other infectious diseases and non-communicable diseases (NCDs). NCDs are an increasing issue with rising morbidity and mortality rates. The World Health Organization (WHO) warns that a lack of nets and treatment could result in up to 18 million additional cases of malaria and up to 30,000 additional deaths in sub-Saharan Africa. OBJECTIVE: Document current prevalence and mortality rates from COVID-19 alongside economic and other measures to reduce its spread and impact across Africa. In addition, suggested ways forward among all key stakeholder groups. OUR APPROACH: Contextualise the findings from a wide range of publications including internet-based publications coupled with input from senior-level personnel. ONGOING ACTIVITIES: Prevalence and mortality rates are currently lower in Africa than among several Western countries and the USA. This could be due to a number of factors including early instigation of lockdown and border closures, the younger age of the population, lack of robust reporting systems and as yet unidentified genetic and other factors. Innovation is accelerating to address concerns with available equipment. There are ongoing steps to address the level of misinformation and its consequences including fines. There are also ongoing initiatives across Africa to start addressing the unintended consequences of COVID-19 activities including lockdown measures and their impact on NCDs including the likely rise in mental health disorders, exacerbated by increasing stigma associated with COVID-19. Strategies include extending prescription lengths, telemedicine and encouraging vaccination. However, these need to be accelerated to prevent increased morbidity and mortality. CONCLUSION: There are multiple activities across Africa to reduce the spread of COVID-19 and address misinformation, which can have catastrophic consequences, assisted by the WHO and others, which appear to be working in a number of countries. Research is ongoing to clarify the unintended consequences given ongoing concerns to guide future activities. Countries are learning from each other.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
The Psychological Impact of Quarantine and How to Reduce It: Rapid Review of the Evidence
Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin, G. J. (2020) · doi:10.2139/ssrn.3532534 · Cited by 16,394
The psychological impact of quarantine and how to reduce it: Rapid review of the evidence
Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin, G. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30460-8 · Cited by 16,378
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475
Wang, C., Pan, R., Wan, X., Tan, Y., Xu, L., Ho, C. S., & Ho, R. C. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17051729 · Cited by 9,923
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Evaluating the quality of medical care
DONABEDIAN, A. (2005) · The Milbank Quarterly · doi:10.1111/j.1468-0009.2005.00397.x · Cited by 6,102
Ekor, M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00177 · Cited by 3,919 · cited 1×
“There are also concerns with the inappropriate use of medicinal plants to prevent and treat COVID-19, which such use particularly prevalent in some sub-Saharan African countries as this can cause more harm than good (Ekor, 2014; Liwa et al., 2014; Nkeck et al., 2020; Nordling, 2020; Yang, 2020).”
BackgroundTimely mental health care for the 2019 novel coronavirus outbreak is urgently needed
Xiang, Y.-T., Yang, Y., Li, W., Zhang, L., Zhang, Q., Cheung, T., & Ng, C. H. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30046-8 · Cited by 3,598
COVID-19 and mental health: A review of the existing literature
Rajkumar, R. P. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102066 · Cited by 3,574 · cited 1×
“…(Brooks et al., 2020; Cullen et al., 2020; Endomba et al., 2020; González-Sanguino et al., 2020; Habersaat et al., 2020; Hwang et al., 2020; Kaufman et al., 2020; Li W. et al., 2020; Rajkumar, 2020; Ren et al., 2020; Wang C. et al., 2020a; Wang C. et al., 2020b; WHO, 2020g; Xiang et al., 2020).”
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
Wang, C., Pan, R., Wan, X., Tan, Y., Xu, L., McIntyre, R. S., Choo, F. N., Tran, B., Ho, R., Sharma, V. K., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.028 · Cited by 2,571
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne, J. A. C., Murthy, S., Diaz, J. V., Slutsky, A. S., Villar, J., Angus, D. C., Annane, D., Azevedo, L. C. P., Berwanger, O., et al. (2020) · JAMA · doi:10.1001/jama.2020.17023 · Cited by 2,257
The COVID-19 pandemic and health inequalities
Bambra, C., Riordan, R., Ford, J., & Matthews, F. (2020) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2020-214401 · Cited by 2,118
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J., Li, Q., Jiang, C., Zhou, Y., Liu, S., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.021 · Cited by 2,074
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., Labella, A., Manson, D. K., Kubin, C., Barr, R. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2012410 · Cited by 1,625
Du, R.-H., Liang, L.-R., Yang, C.-Q., Wang, W., Cao, T.-Z., Li, M., Guo, G.-Y., Du, J., Zheng, C.-L., Zhu, Q., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00524-2020 · Cited by 1,452
Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing
Wang, C. J., Ng, C. Y., & Brook, R. H. (2020) · JAMA · doi:10.1001/jama.2020.3151 · Cited by 1,391
González-Sanguino, C., Ausín, B., Castellanos, M. Á., Saiz, J., López-Gómez, A., Ugidos, C., & Muñoz, M. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.040 · Cited by 1,373
Mental health in the COVID-19 pandemic
Cullen, W., Gulati, G., & Kelly, B. D. (2020) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcaa110 · Cited by 1,275
Tomazini, B. M., Maia, I. S., Cavalcanti, A. B., Berwanger, O., Rosa, R. G., Veiga, V. C., Avezum, A., Lopes, R. D., Bueno, F. R., Silva, M. V. A. O., et al. (2020) · JAMA · doi:10.1001/jama.2020.17021 · Cited by 1,241 · cited 1×
“Other recent studies have also shown benefit from corticosteroids in critically ill patients increasing the number of days alive and free of mechanical ventilation as well as reducing mortality (Sterne et al., 2020; Tomazini et al., 2020).”
BackgroundProgression of Mental Health Services during the COVID-19 Outbreak in China
Li, W., Yang, Y., Liu, Z.-H., Zhao, Y.-J., Zhang, Q., Zhang, L., Cheung, T., & Xiang, Y.-T. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45120 · Cited by 1,213
Castagnoli, R., Votto, M., Licari, A., Brambilla, I., Bruno, R., Perlini, S., Rovida, F., Baldanti, F., & Marseglia, G. L. (2020) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2020.1467 · Cited by 1,085
Loneliness and social isolation during the COVID-19 pandemic
Hwang, T.-J., Rabheru, K., Peisah, C., Reichman, W., & Ikeda, M. (2020) · International Psychogeriatrics · doi:10.1017/s1041610220000988 · Cited by 1,044
Borba, M. G. S., Val, F. F. A., Sampaio, V. S., Alexandre, M. A. A., Melo, G. C., Brito, M., Mourão, M. P. G., Brito-Sousa, J. D., Baía-da-Silva, D., Guerra, M. V. F., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8857 · Cited by 1,038
Virtual health care in the era of COVID-19
Webster, P. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30818-7 · Cited by 769
Bode, B., Garrett, V., Messler, J., McFarland, R., Crowe, J., Booth, R., & Klonoff, D. C. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820924469 · Cited by 766
Obesity and its implications for covid-19 mortality
Dietz, W., & Santos‐Burgoa, C. (2020) · Obesity · doi:10.1002/oby.22818 · Cited by 687
Ethnicity and COVID-19: an urgent public health research priority
Pareek, M., Bangash, M. N., Pareek, N., Pan, D., Sze, S., Minhas, J. S., Hanif, W., & Khunti, K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30922-3 · Cited by 426
Zheng, S.-Q., Yang, L., Zhou, P.-X., Li, H.-B., Liu, F., & Zhao, R.-S. (2021) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.03.012 · Cited by 333
COVID-19 Pandemic, a War to be Won: Understanding its Economic Implications for Africa
Ataguba, J. E. (2020) · Applied Health Economics and Health Policy · doi:10.1007/s40258-020-00580-x · Cited by 295 · cited 5×
“Containing the spread and impact of COVID-19, including the substantial economic impact, will though require a multipronged approach and co-operation among all key stakeholder groups going forward, including patients, with countries learning from each other (Ataguba, 2020).”
BackgroundInfluentialBuecker, S., & Horstmann, K. T. (2021) · European Psychologist · doi:10.1027/1016-9040/a000453 · Cited by 225
COVID-19: A public health approach to manage domestic violence is needed
Chandan, J. S., Taylor, J., Bradbury-Jones, C., Nirantharakumar, K., Kane, E., & Bandyopadhyay, S. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30112-2 · Cited by 221
Medicine Shortages: Gaps Between Countries and Global Perspectives
Acosta, A., Vanegas, E. P., Rovira, J., Godman, B., & Bochenek, T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00763 · Cited by 147
Self-citationModisakeng, C., Matlala, M., Godman, B., & Meyer, J. C. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-05080-1 · Cited by 130 · cited 1×
“However, African countries are already taking steps to address concerns with shortages before and during the pandemic including suggesting potential alternatives (Chigome et al., 2019; Medical Brief, 2020b; Modisakeng et al., 2020; Review Online, 2020; Tomlinson, 2020).”
BackgroundSelf-citationBochenek, T., Abilova, V., Alkan, A., Asanin, B., de Miguel Beriain, I., Besovic, Z., Vella Bonanno, P., Bucsics, A., Davidescu, M., De Weerdt, E., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00942 · Cited by 112
Self-citationCovid-19: most patients require mechanical ventilation in first 24 hours of critical care
Mahase, E. (2020) · BMJ · doi:10.1136/bmj.m1201 · Cited by 79 · cited 2×
“There are also reports of an increase in gender-based violence across countries, including African countries, as a result of lockdown measures, which also needs addressing going forward (Campbell, 2020; Chandan et al., 2020; Mahase, 2020b; SADC, 2020; United Nations., 2020b).”
BackgroundImplications of non-prescription antibiotic sales in China
Kalungia, A., & Godman, B. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30408-6 · Cited by 47
Self-citation
Cited by
Sono, T. M., Yeika, E., Cook, A., Kalungia, A., Opanga, S. A., Acolatse, J. E. E., Sefah, I. A., Jelić, A. G., Campbell, S., Lorenzetti, G., et al. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2259106 · Cited by 95
Self-citationAdebesin, F., Smuts, H., Mawela, T., Maramba, G., & Hattingh, M. (2023) · JMIR Infodemiology · doi:10.2196/48620 · Cited by 57
Metadata
- Authors
- Ogunleye, O. O., Basu, D., Mueller, D., Sneddon, J., Seaton, R. A., Yinka-Ogunleye, A. F., Wamboga, J., Miljković, N., Mwita, J. C., Rwegerera, G. M., Massele, A., Patrick, O., Niba, L. L., Nsaikila, M., Rashed, W. M., Hussein, M. A., Hegazy, R., Amu, A. A., Boahen-Boaten, B. B., Matsebula, Z., Gwebu, P., Chirigo, B., Mkhabela, N., Dlamini, T., Sithole, S., Malaza, S., Dlamini, S., Afriyie, D., Asare, G. A., Amponsah, S. K., Sefah, I., Oluka, M., Guantai, A. N., Opanga, S. A., Sarele, T. V., Mafisa, R. K., Chikowe, I., Khuluza, F., Kibuule, D., Kalemeera, F., Mubita, M., Fadare, J., Sibomana, L., Ramokgopa, G. M., Whyte, C., Maimela, T., Hugo, J., Meyer, J. C., Schellack, N., Rampamba, E. M., Visser, A., Alfadl, A., Malik, E. M., Malande, O. O., Kalungia, A. C., Mwila, C., Zaranyika, T., Chaibva, B. V., Olaru, I. D., Masuka, N., Wale, J., Hwenda, L., Kamoga, R., Hill, R., Barbui, C., Bochenek, T., Kurdi, A., Campbell, S., Martin, A. P., Phuong, T. N. T., Thanh, B. N., & Godman, B.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2020-09-11
- Volume
- 11
- Pages
- 1205-1205
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3048223582
- Cited by
- 208
- References
- 41
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.